BST2 and breast carcinoma: They found overexpression of BST2 in the bone metastatic breast cancer tissues (compared to nonbone metastatic breast cancer tissues), as well as elevated BST2 levels in breast cancer patients with bone metastasis (compared to breast cancer patients without bone metastasis) [27].